Trademark Overview
On Wednesday, October 8, 2025, a trademark application was filed for MYTAARI with the United States Patent and Trademark Office. The USPTO has given the MYTAARI trademark a serial number of 99432608. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, October 8, 2025. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The MYTAARI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of cognitive disorders; pharmaceutical preparations for the treatment of major depressive disorder; pharmaceutical preparations for the treatment of generalized anxiety disorder.